Precision Optics Corporation, Inc. — Form 10-Q Summary
Reporting period: First quarter of fiscal 2020, the three months ended September 30, 2019. The unaudited consolidated statements compare with the three months ended September 30, 2018; balance-sheet figures compare with June 30, 2019.
Business context
Precision Optics designs and manufactures optical instruments and medical-device products, including endoscopes and imaging components. The quarter includes Ross Optical, acquired effective June 1, 2019; Ross supplies custom and catalog optical components and assemblies. Management said Ross contributed $1.09 million of quarterly revenue.
Financial performance and liquidity
| Metric | Quarter ended Sep. 30, 2019 | Prior-year quarter | Change / context |
|---|---|---|---|
| Revenue | $2.515 million | $1.559 million | Up 61.3%, primarily reflecting Ross; non-Ross revenue declined $135,298. |
| Gross profit / margin | $974,117 / 38.7% | $462,507 / 29.7% | Gross profit up 110.6%; management attributed the margin improvement largely to Ross’s 48% gross margin versus 32% for non-Ross revenue. |
| Operating loss | $85,882 | $298,780 | Loss narrowed. |
| Net loss / loss per share | $86,110 / $0.01 | $299,285 / $0.03 | Loss narrowed; weighted-average shares increased to 12.83 million from 10.26 million. |
| Operating cash flow | $1,347 provided | $6,430 used | Near break-even cash generation from operations. |
| Cash and cash equivalents | $849,135 | $2.288 million at June 30, 2019 | Declined $1.439 million during the quarter, principally alongside $1.443 million paid for the acquisition. |
| Current assets / current liabilities | $4.748 million / $1.984 million | $6.368 million / $3.611 million at June 30, 2019 | Working capital was approximately $2.764 million; current ratio approximately 2.4. |
Research and development expense increased 50.9% to $152,154; selling, general and administrative expense rose 37.5% to $907,845, including $273,055 of Ross expenses. Total assets were $6.037 million and stockholders’ equity was $3.446 million at September 30. Capital-lease obligations totaled $12,266; operating-lease liabilities totaled $158,690. The balance sheet also included a $500,000 acquisition earn-out liability and $513,623 of customer advances.
Material changes and unusual items
- Ross Optical expanded the company’s component and assembly business and drove most of the reported revenue increase. Revenue mix included $1.416 million of optical components, $689,012 of medical-device products and assemblies, and $409,728 of engineering design services.
- The company paid $1.443 million for the business acquisition during the quarter. It adopted lease accounting standard ASC 842 on July 1, 2019 and recorded a $158,690 operating-lease right-of-use asset and corresponding lease liabilities.
- The company issued 760,000 shares in a private placement and reported 12,868,639 shares outstanding at September 30. It also issued 25,000 shares valued at $45,000 for investor-relations services.
- Quarter-end open purchase-order commitments were approximately $1.217 million, in addition to remaining capital- and operating-lease commitments of $12,266 and $170,172, respectively.
Outlook, risks and controls
No numerical revenue or earnings guidance was provided. Management said profitability depends on achieving sufficient quarterly revenue and gross margins, controlling operating expenses, and collecting receivables promptly. It expects its development pipeline and production projects to have potential to increase revenue, but emphasized that results can fluctuate with sales mix and project stages.
Management cited recurring losses, customer pricing pressure, engineering and production cost overruns, and margin variability. The company competes with larger, better-resourced domestic and foreign businesses. Its three largest customers represented approximately 28% of quarterly sales, although no single customer exceeded 10%. Management reported that disclosure controls and internal control over financial reporting were ineffective at September 30, citing material weaknesses in segregation of duties and inventory valuation. It said remediation efforts continue but cannot be assured of success. Management reported no pending or threatened litigation known to have a material impact and no material off-balance-sheet arrangements.
Important facts for investors to verify
- Private-placement proceeds discrepancy: The filing’s Part II says 760,000 shares were sold at $1.25 per share for $950,000 gross proceeds. However, the equity statement records only $25,000 for the 760,000-share issuance, and the cash-flow statement reports $25,000 of private-placement proceeds. Reconcile the transaction terms, cash received, accounting presentation, and use of proceeds.
- Review Ross Optical’s acquisition consideration, earn-out terms, and contribution to results; the filing reports the acquisition cash payment and earn-out liability but does not present a full purchase-price allocation in the provided text.
- Assess cash runway and working-capital requirements against open purchase orders, customer advances, receivable collections, and continued operating losses.
- Monitor remediation of the disclosed material weaknesses, particularly inventory valuation and segregation of accounting duties.
- Track whether the expected pipeline converts to production revenue and whether non-Ross gross margins improve as management anticipates.